7/30/2013 6:50:35 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Genesis Biopharma, Inc. (OTCBB: GNBP) today announced the appointment of Sanford J. Hillsberg and Jay Venkatesan, MD, to its board of directors. Genesis also announced that Paul Kessler and David Voyticky have tendered their resignations as directors. The appointment of Dr. Venkatesan and Mr. Hillsberg, and the resignations of Mr. Kessler and Mr. Voyticky will become effective in approximately two weeks, following the completion of certain regulatory filings and procedures.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by